MALIGNANCY
Clinical trials for MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new MALIGNANCY trials appear
Sign up with your email to follow new studies for MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study offers hope for girls facing infertility from medical treatments
Disease control Recruiting nowThis study offers girls facing fertility-threatening medical treatments the option to freeze their ovarian tissue for future use. Up to 40 participants will have a small piece of ovary removed laparoscopically and stored. The goal is to see how many choose this option and at what…
Matched conditions: MALIGNANCY
Phase: NA • Sponsor: Phoenix Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Cheap steel wires may outperform costly cement in chest reconstruction
Disease control Recruiting nowThis study compares two ways to rebuild the chest wall after removing a tumor: using twisted steel wires versus bone cement. The goal is to see which method causes less pain, helps breathing better, and has fewer complications. About 50 adults needing chest wall reconstruction wi…
Matched conditions: MALIGNANCY
Phase: NA • Sponsor: University of Health Sciences Lahore • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Could a lung cancer drug work for other rare tumors? new trial aims to find out.
Disease control Recruiting nowThis trial tests capmatinib, a drug already approved for certain lung cancers, in adults with rare cancers that have specific MET gene changes. About 30 participants will receive the drug to see if it can shrink tumors or stop them from growing for at least 24 weeks. The goal is …
Matched conditions: MALIGNANCY
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a lung cancer drug treat rare tumors? new trial aims to find out
Disease control Recruiting nowThis trial tests the drug entrectinib (Rozlytrek) in people with rare cancers that have a specific genetic change called ROS1 fusion. The drug is already approved for some lung cancers, but researchers want to see if it works for other tumor types. About 30 adults, teens, and chi…
Matched conditions: MALIGNANCY
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a common cancer drug help rare tumors? new trial aims to find out
Disease control Recruiting nowThis trial tests atezolizumab, a drug already approved for several cancers, in people with rare cancers that have high tumor mutational burden (TMB) or microsatellite instability (MSI). The goal is to see if the drug can shrink tumors or stop them from growing for at least 24 wee…
Matched conditions: MALIGNANCY
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New device aims to make cancer biopsies more precise
Diagnosis Recruiting nowThis study tests a new imaging device called tVisio-1 that helps doctors see tumor tissue before taking a biopsy sample. The goal is to make biopsies more accurate and reduce complications. About 150 adults with suspected or confirmed cancer will participate at MD Anderson Cancer…
Matched conditions: MALIGNANCY
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
New PET scan technique could sharpen cancer detection in the gut
Diagnosis Recruiting nowThis study is testing a new type of PET scan that uses special probes to highlight digestive system cancers, such as stomach, liver, colon, and pancreatic cancers. Researchers will enroll 400 adults to see how well this imaging method finds tumors and tracks their response to tre…
Matched conditions: MALIGNANCY
Phase: NA • Sponsor: RenJi Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Which sedation works best for bile duct procedures? new study aims to find out
Symptom relief Recruiting nowThis study compares two types of sedation used during a procedure to drain blocked bile ducts. About 98 adults will receive either propofol-remifentanil or propofol-ketamine. The goal is to see which method leads to faster recovery, better comfort, and fewer side effects, especia…
Matched conditions: MALIGNANCY
Phase: NA • Sponsor: Ankara City Hospital Bilkent • Aim: Symptom relief
Last updated Jun 27, 2026 13:08 UTC
-
One-Shot radiation hope for bulky tumors
Symptom relief Recruiting nowThis study tests a single, high-dose radiation treatment called spatially fractionated radiation (SFR) for people with large tumors (over 8 cm) or tumors that resist standard radiation. The goal is to see if one session can relieve symptoms as well as multiple sessions, with fewe…
Matched conditions: MALIGNANCY
Phase: NA • Sponsor: Sir Mortimer B. Davis - Jewish General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Could a zap to the brain's master gland ease cancer pain?
Symptom relief Recruiting nowThis early-stage study tests whether a precise radiation dose to the pituitary gland (hypophysectomy) can safely reduce severe cancer pain that hasn't responded to standard treatments like opioids. About 40 adults with advanced cancer and hard-to-control pain will receive this on…
Matched conditions: MALIGNANCY
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Cancer survivors may carry hidden aging markers that raise disease risk
Knowledge-focused Recruiting nowThis study will compare levels of fatty acid binding proteins and cellular aging markers in 120 cancer survivors versus people who never had cancer. Researchers want to see if these markers are higher in survivors and linked to conditions like diabetes and high blood pressure. Pa…
Matched conditions: MALIGNANCY
Sponsor: Case Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jul 02, 2026 01:00 UTC
-
Scientists seek tissue samples to unlock HIV and cancer mysteries
Knowledge-focused Recruiting nowThis study collects blood, bone marrow, and tissue samples from people with HIV, KSHV, or certain cancers to help researchers learn more about these diseases. Participants must be 18 or older and may have HIV, KSHV, or related conditions. No treatment is given; the goal is to gat…
Matched conditions: MALIGNANCY
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Scientists launch massive tumor repository to unlock cancer secrets
Knowledge-focused Recruiting nowThis study collects extra blood, urine, and tumor samples from children and adults with certain cancers to build a large tissue repository. Researchers will analyze these samples to learn more about the genetic and molecular makeup of these tumors. The goal is to support future s…
Matched conditions: MALIGNANCY
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New biobank aims to unlock secrets of Immunotherapy's harsh side effects
Knowledge-focused Recruiting nowThis study collects blood, tissue, and medical information from 240 cancer patients who have had serious side effects from immunotherapy. The goal is to store these samples in a national biorepository for future research. By studying these samples, scientists hope to better predi…
Matched conditions: MALIGNANCY
Sponsor: Alliance for Clinical Trials in Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Oxygen therapy under scrutiny: could it harm cancer Survivors' DNA?
Knowledge-focused Recruiting nowThis study looks at whether repeated sessions of hyperbaric oxygen therapy (HBOT) can damage DNA in people who have had radiation for cancer. HBOT is used to help heal tissues damaged by radiation, but it also creates reactive oxygen molecules that might harm DNA. Researchers wil…
Matched conditions: MALIGNANCY
Phase: NA • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC